Integra Lifesciences (IART) Misses Q1 EPS by 30c; Trims Outlook

May 2, 2013 9:32 AM

Integra Lifesciences Holdings (NASDAQ: IART) reported Q1 EPS of $0.39, $0.30 worse than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found